Literature DB >> 35395179

Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.

Aikun Fu1, Bingqing Yao2, Tingting Dong2, Yongyi Chen3, Jia Yao4, Yu Liu4, Hang Li5, Huiru Bai2, Xiaoqin Liu6, Yue Zhang2, Chunhui Wang7, Yajing Guo8, Nan Li5, Shang Cai9.   

Abstract

Tumor-resident intracellular microbiota is an emerging tumor component that has been documented for a variety of cancer types with unclear biological functions. Here, we explored the functional significance of these intratumor bacteria, primarily using a murine spontaneous breast-tumor model MMTV-PyMT. We found that depletion of intratumor bacteria significantly reduced lung metastasis without affecting primary tumor growth. During metastatic colonization, intratumor bacteria carried by circulating tumor cells promoted host-cell survival by enhancing resistance to fluid shear stress by reorganizing actin cytoskeleton. We further showed that intratumor administration of selected bacteria strains isolated from tumor-resident microbiota promoted metastasis in two murine tumor models with significantly different levels of metastasis potential. Our findings suggest that tumor-resident microbiota, albeit at low biomass, play an important role in promoting cancer metastasis, intervention of which might therefore be worth exploring for advancing oncology care.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  breast cancer metastasis; circulating tumor cells; cytoskeleton reorganization; fluid shear stress; intracellular bacteria; intratumor microbiota; metastatic colonization

Mesh:

Year:  2022        PMID: 35395179     DOI: 10.1016/j.cell.2022.02.027

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  22 in total

1.  Using local hyperthermia therapy to induce browning of WAT.

Authors:  Claire Greenhill
Journal:  Nat Rev Endocrinol       Date:  2022-05       Impact factor: 43.330

Review 2.  Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches.

Authors:  Priyankar Dey; Saumya Ray Chaudhuri
Journal:  Biology (Basel)       Date:  2022-05-16

Review 3.  Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer.

Authors:  Shawn Ying Xuan Tan; Jieqiong Zhang; Wee-Wei Tee
Journal:  Front Cell Dev Biol       Date:  2022-06-08

Review 4.  Current Status and Future Directions of Bacteria-Based Immunotherapy.

Authors:  Quan Tang; Xian Peng; Bo Xu; Xuedong Zhou; Jing Chen; Lei Cheng
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

5.  Bacteria in tumors "hit the road" together.

Authors:  Gregory D Longmore
Journal:  Cell       Date:  2022-04-14       Impact factor: 66.850

Review 6.  Targeting the gut microbiota for cancer therapy.

Authors:  Miriam R Fernandes; Poonam Aggarwal; Raquel G F Costa; Alicia M Cole; Giorgio Trinchieri
Journal:  Nat Rev Cancer       Date:  2022-10-17       Impact factor: 69.800

Review 7.  Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review.

Authors:  Ruo-Gu Xiong; Si-Yu Huang; Si-Xia Wu; Dan-Dan Zhou; Zhi-Jun Yang; Adila Saimaiti; Cai-Ning Zhao; Ao Shang; Yun-Jian Zhang; Ren-You Gan; Hua-Bin Li
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

8.  Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.

Authors:  Han Qiao; Xi-Rong Tan; Hui Li; Jun-Yan Li; Xiao-Zhong Chen; Ying-Qin Li; Wen-Fei Li; Ling-Long Tang; Guan-Qun Zhou; Yuan Zhang; Ye-Lin Liang; Qing-Mei He; Yin Zhao; Sheng-Yan Huang; Sha Gong; Qian Li; Ming-Liang Ye; Kai-Lin Chen; Ying Sun; Jun Ma; Na Liu
Journal:  JAMA Oncol       Date:  2022-09-01       Impact factor: 33.006

Review 9.  The Role of The Tumor Microbiome in Tumor Development and Its Treatment.

Authors:  Yan Chen; Fa-Hong Wu; Peng-Qiang Wu; Hong-Yun Xing; Tao Ma
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

Review 10.  The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine.

Authors:  Martina Di Modica; Valeria Arlotta; Lucia Sfondrini; Elda Tagliabue; Tiziana Triulzi
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.